There are still significant unmet needs among these patients, many of whom continue to report significant residual symptoms, including pain, fatigue, and functional disability, according to a systematic review.
Both MSUS and MRI are valuable imaging modalities for diagnosis and monitoring of patients with RA, may predict radiographic progression and tapering failure and identify subclinical inflammation.
The study reports on the risk of incident breast cancer in women with RA, and the risk of RA in women with a history of breast cancer, taking antihormonal treatment for breast cancer into account.
The study results demonstrate that specific ACPA and RF isotypes associate with the presence of parenchymal lunch abnormalities already at disease onset and before any treatment initiation in patients with RA.